A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)
Clinical trial NCT06077864 · COMPLETED
Trial details
- NCT number
- NCT06077864
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-20
- Primary completion
- 2026-06-01
- Enrollment
- 5531
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.